Polaris Pharmaceuticals Incis A Multinational Biotechnology Company Founded In 2006 And Based In Taipeitaiwanthe Company Has A Strong Focus On Developing Novel Anti Cancer Therapiesparticularly Through Its Flagship Productadi Peg 20Pegargiminase This Biologic Therapy Is In Late Phase Clinical Development And Has Been Tested In Over 20 Global Trialstargeting Various Cancers Such As Mesotheliomasarcomaand Acute Myeloid Leukemia Polaris Operates Subsidiaries In The U S Taiwanchinaaustraliairelandand Hong Kongwith Facilities In San Diego And Vacavillecaliforniathe Company Is Publicly Traded On The Taiwan Stock Exchange And Emphasizes Drug Manufacturingbiotechnology Servicesand Clinical Drug Testingpolaris Is Dedicated To Advancing Its Oncology Pipelines And Reinvests Its Earnings Into Research And Development To Support Its Mission Of Providing Effective Treatments For Cancers That Currently Lack Options
No conferences found for this company.
| Company Name | Polaris Pharmaceuticals Inc |
| Country |
United States
|
| Address | 9373 Towne Centre Drivesuite 150San Diego Ca 92121United States |
| Telephone | Login to View |
| Login to View |
